Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Objective assessment of a relative afferent pupillary defect by B-mode ultrasound.

Schmidt FA, Connolly F, Maas MB, Grittner U, Harms L, Brandt A, Paul F, Schreiber S, Ruprecht K.

PLoS One. 2018 Aug 27;13(8):e0202774. doi: 10.1371/journal.pone.0202774. eCollection 2018.

2.

Assessment and comparison of the max-ICH score and ICH score by external validation.

Schmidt FA, Liotta EM, Prabhakaran S, Naidech AM, Maas MB.

Neurology. 2018 Sep 4;91(10):e939-e946. doi: 10.1212/WNL.0000000000006117. Epub 2018 Aug 1.

PMID:
30068631
3.

Inter-rater Agreement for the Diagnosis of Stroke Versus Stroke Mimic.

Liberman AL, Rostanski SK, Ruff IM, Meyer AND, Maas MB, Prabhakaran S.

Neurologist. 2018 Jul;23(4):118-121. doi: 10.1097/NRL.0000000000000187.

PMID:
29953034
4.

Prophylactic Seizure Medication and Health-Related Quality of Life After Intracerebral Hemorrhage.

Naidech AM, Beaumont J, Muldoon K, Liotta EM, Maas MB, Potts MB, Jahromi BS, Cella D, Prabhakaran S, Holl JL.

Crit Care Med. 2018 Sep;46(9):1480-1485. doi: 10.1097/CCM.0000000000003272.

PMID:
29923930
5.

The authors reply.

Liotta EM, Ganger D, Ladner DP, Maas MB.

Crit Care Med. 2018 Jul;46(7):e728-e729. doi: 10.1097/CCM.0000000000003180. No abstract available.

PMID:
29912130
6.

Education Research: Variation in priorities for neurocritical care education expressed across role groups.

Cohen AS, Izzy S, Kumar MA, Joyce CJ, Figueroa SA, Maas MB, Hall CE, McDonagh DL, Lerner DP, Vespa PM, Shutter LA, Rosenthal ES.

Neurology. 2018 Jun 12;90(24):1117-1122. doi: 10.1212/WNL.0000000000005682.

PMID:
29891575
7.

Author response: Magnesium, hemostasis, and outcomes in patients with intracerebral hemorrhage.

Liotta EM, Prabhakaran S, Maas MB.

Neurology. 2018 Apr 3;90(14):667. doi: 10.1212/WNL.0000000000005272. No abstract available.

PMID:
29610232
8.

Fever Burden and Health-Related Quality of Life After Intracerebral Hemorrhage.

Bush RA, Beaumont JL, Liotta EM, Maas MB, Naidech AM.

Neurocrit Care. 2018 Mar 29. doi: 10.1007/s12028-018-0523-y. [Epub ahead of print]

PMID:
29600341
9.

Oxidative Stress Biomarkers of Brain Damage: Hyperacute Plasma F2-Isoprostane Predicts Infarct Growth in Stroke.

Lorenzano S, Rost NS, Khan M, Li H, Lima FO, Maas MB, Green RE, Thankachan TK, Dipietro AJ, Arai K, Som AT, Pham LD, Wu O, Harris GJ, Lo EH, Blumberg JB, Milbury PE, Feske SK, Furie KL.

Stroke. 2018 Mar;49(3):630-637. doi: 10.1161/STROKEAHA.117.018440. Epub 2018 Jan 25.

PMID:
29371434
10.

Osmotic Shifts, Cerebral Edema, and Neurologic Deterioration in Severe Hepatic Encephalopathy.

Liotta EM, Romanova AL, Lizza BD, Rasmussen-Torvik LJ, Kim M, Francis B, Sangha RS, Carroll TJ, Ganger D, Ladner DP, Naidech AM, Paparello JJ, Prabhakaran S, Sorond FA, Maas MB.

Crit Care Med. 2018 Feb;46(2):280-289. doi: 10.1097/CCM.0000000000002831.

PMID:
29341965
11.

Medication History versus Point-of-Care Platelet Activity Testing in Patients with Intracerebral Hemorrhage.

Maas MB, Naidech AM, Kim M, Batra A, Manno EM, Sorond FA, Prabhakaran S, Liotta EM.

J Stroke Cerebrovasc Dis. 2018 May;27(5):1167-1173. doi: 10.1016/j.jstrokecerebrovasdis.2017.11.033. Epub 2018 Jan 5.

PMID:
29310956
12.

Ecological Validity in the Critical Care Environment: Closing the Loop on Evidence Based Medicine.

Maas MB.

Respir Care. 2018 Jan;63(1):119-120. doi: 10.4187/respcare.06015. No abstract available.

PMID:
29237867
13.

B-mode ultrasound assessment of pupillary function: Feasibility, reliability and normal values.

Schmidt FA, Ruprecht K, Connolly F, Maas MB, Paul F, Hoffmann J, Harms L, Schreiber SJ.

PLoS One. 2017 Dec 6;12(12):e0189016. doi: 10.1371/journal.pone.0189016. eCollection 2017.

14.

The State of Neurocritical Care Fellowship Training and Attitudes toward Accreditation and Certification: A Survey of Neurocritical Care Fellowship Program Directors.

Dhar R, Rajajee V, Finley Caulfield A, Maas MB, James ML, Kumar AB, Figueroa SA, McDonagh D, Ardelt A.

Front Neurol. 2017 Nov 3;8:548. doi: 10.3389/fneur.2017.00548. eCollection 2017.

15.

Borosilicate Glass Fiber-Optic Biosensor for the Detection of Escherichia coli.

Maas MB, Maybery GHC, Perold WJ, Neveling DP, Dicks LMT.

Curr Microbiol. 2018 Feb;75(2):150-155. doi: 10.1007/s00284-017-1359-y. Epub 2017 Oct 24.

PMID:
29063970
16.

Impact of Multiple Daily Clinical Pharmacist-Enforced Assessments on Time in Target Sedation Range.

Lizza BD, Jagow B, Hensler D, Cooper CJ, Short EJ, Maas MB, Naidech AM, Wunderink RG.

J Pharm Pract. 2018 Oct;31(5):445-449. doi: 10.1177/0897190017729522. Epub 2017 Sep 6.

PMID:
28874082
17.

Magnesium, hemostasis, and outcomes in patients with intracerebral hemorrhage.

Liotta EM, Prabhakaran S, Sangha RS, Bush RA, Long AE, Trevick SA, Potts MB, Jahromi BS, Kim M, Manno EM, Sorond FA, Naidech AM, Maas MB.

Neurology. 2017 Aug 22;89(8):813-819. doi: 10.1212/WNL.0000000000004249. Epub 2017 Jul 26.

18.

A resident boot camp for reducing door-to-needle times at academic medical centers.

Ruff IM, Liberman AL, Caprio FZ, Maas MB, Mendelson SJ, Sorond FA, Bergman D, Bernstein RA, Curran Y, Prabhakaran S.

Neurol Clin Pract. 2017 Jun;7(3):237-245. doi: 10.1212/CPJ.0000000000000367. Review.

19.

Olfactory dysfunction in patients with primary progressive MS.

Schmidt FA, Maas MB, Geran R, Schmidt C, Kunte H, Ruprecht K, Paul F, Göktas Ö, Harms L.

Neurol Neuroimmunol Neuroinflamm. 2017 Jun 14;4(4):e369. doi: 10.1212/NXI.0000000000000369. eCollection 2017 Jul.

20.

Wake-Up Stroke Is Associated With Greater Nocturnal Mean Arterial Pressure Variability.

Lundholm MD, Rooney M, Maas MB, Attarian H, Prabhakaran S.

Stroke. 2017 Jun;48(6):1668-1670. doi: 10.1161/STROKEAHA.116.016202. Epub 2017 Apr 28.

PMID:
28455315
21.

Is Neck Dissection Associated with an Increased Risk of Postoperative Stroke?

Cramer JD, Patel UA, Maas MB, Samant S, Smith SS.

Otolaryngol Head Neck Surg. 2017 Aug;157(2):226-232. doi: 10.1177/0194599817698414. Epub 2017 Apr 18.

PMID:
28417663
22.

Abnormal environmental light exposure in the intensive care environment.

Fan EP, Abbott SM, Reid KJ, Zee PC, Maas MB.

J Crit Care. 2017 Aug;40:11-14. doi: 10.1016/j.jcrc.2017.03.002. Epub 2017 Mar 7.

23.

Refining Prognosis for Intracerebral Hemorrhage by Early Reassessment.

Maas MB, Francis BA, Sangha RS, Lizza BD, Liotta EM, Naidech AM.

Cerebrovasc Dis. 2017;43(3-4):110-116. doi: 10.1159/000452679. Epub 2017 Jan 4.

24.

Critical Care Neurology Perspective on Delirium.

Maas MB, Naidech AM.

Semin Neurol. 2016 Dec;36(6):601-606. Epub 2016 Dec 1. Review.

PMID:
27907964
25.

Agitation, Delirium, and Cognitive Outcomes in Intracerebral Hemorrhage.

Rosenthal LJ, Francis BA, Beaumont JL, Cella D, Berman MD, Maas MB, Liotta EM, Askew R, Naidech AM.

Psychosomatics. 2017 Jan - Feb;58(1):19-27. doi: 10.1016/j.psym.2016.07.004. Epub 2016 Aug 5.

26.

High-flow oxygen therapy for treatment of acute migraine: A randomized crossover trial.

Singhal AB, Maas MB, Goldstein JN, Mills BB, Chen DW, Ayata C, Kacmarek RM, Topcuoglu MA.

Cephalalgia. 2017 Jul;37(8):730-736. doi: 10.1177/0333102416651453. Epub 2016 May 20.

PMID:
27206964
27.

23.4% Saline Decreases Brain Tissue Volume in Severe Hepatic Encephalopathy as Assessed by a Quantitative CT Marker.

Liotta EM, Lizza BD, Romanova AL, Guth JC, Berman MD, Carroll TJ, Francis B, Ganger D, Ladner DP, Maas MB, Naidech AM.

Crit Care Med. 2016 Jan;44(1):171-9. doi: 10.1097/CCM.0000000000001276.

28.

Neurochecks as a Biomarker of the Temporal Profile and Clinical Impact of Neurologic Changes after Intracerebral Hemorrhage.

Maas MB, Berman MD, Guth JC, Liotta EM, Prabhakaran S, Naidech AM.

J Stroke Cerebrovasc Dis. 2015 Sep;24(9):2026-31. doi: 10.1016/j.jstrokecerebrovasdis.2015.04.045. Epub 2015 Jul 2.

29.

Do efforts to decrease door-to-needle time risk increasing stroke mimic treatment rates?

Liberman AL, Liotta EM, Caprio FZ, Ruff I, Maas MB, Bernstein RA, Khare R, Bergman D, Prabhakaran S.

Neurol Clin Pract. 2015 Jun;5(3):247-252.

30.

Dichotomous "Good Outcome" Indicates Mobility More Than Cognitive or Social Quality of Life.

Naidech AM, Beaumont JL, Berman M, Francis B, Liotta E, Maas MB, Prabhakaran S, Holl J, Cella D.

Crit Care Med. 2015 Aug;43(8):1654-9. doi: 10.1097/CCM.0000000000001082.

31.

Comment: intraventricular hemorrhage--it's the blood that matters, not the timing.

Maas MB.

Neurology. 2015 Mar 10;84(10):993. doi: 10.1212/WNL.0000000000001348. Epub 2015 Feb 6. No abstract available.

PMID:
25663220
32.

Acute changes in ventricular volume during treatment for hepatic and renal failure.

Liotta EM, Bauer RM, Berman MD, Guth JC, Maas MB, Naidech AM, Rosenberg NF.

Neurol Clin Pract. 2014 Dec;4(6):478-481. No abstract available.

33.

Web-Based Assessment of Outcomes After Subarachnoid and Intracerebral Hemorrhage: A New Patient Centered Option for Outcomes Assessment.

Naidech AM, Beaumont JL, Berman M, Liotta E, Maas MB, Prabhakaran S, Kording K, Holl J, Cella D.

Neurocrit Care. 2015 Aug;23(1):22-7. doi: 10.1007/s12028-014-0098-1.

PMID:
25510897
34.

Subarachnoid extension of hemorrhage is associated with early seizures in primary intracerebral hemorrhage.

Guth JC, Gerard EE, Nemeth AJ, Liotta EM, Prabhakaran S, Naidech AM, Maas MB.

J Stroke Cerebrovasc Dis. 2014 Nov-Dec;23(10):2809-13. doi: 10.1016/j.jstrokecerebrovasdis.2014.07.023. Epub 2014 Sep 4.

PMID:
25194742
35.

Magnetic resonance imaging versus computed tomography for identification and quantification of intraventricular hemorrhage.

Romanova AL, Nemeth AJ, Berman MD, Guth JC, Liotta EM, Naidech AM, Maas MB.

J Stroke Cerebrovasc Dis. 2014 Sep;23(8):2036-2040. doi: 10.1016/j.jstrokecerebrovasdis.2014.03.005. Epub 2014 Jul 30.

36.

Desmopressin improves platelet activity in acute intracerebral hemorrhage.

Naidech AM, Maas MB, Levasseur-Franklin KE, Liotta EM, Guth JC, Berman M, Rosenow JM, Lindholm PF, Bendok BR, Prabhakaran S, Bernstein RA, Kwaan HC.

Stroke. 2014 Aug;45(8):2451-3. doi: 10.1161/STROKEAHA.114.006061. Epub 2014 Jul 8.

PMID:
25005444
37.

Pearls & oy-sters: bilateral thalamic involvement in West Nile virus encephalitis.

Guth JC, Futterer SA, Hijaz TA, Liotta EM, Rosenberg NF, Naidech AM, Maas MB.

Neurology. 2014 Jul 8;83(2):e16-7. doi: 10.1212/WNL.0000000000000571. No abstract available.

38.

Diagnostic yield of pelvic magnetic resonance venography in patients with cryptogenic stroke and patent foramen ovale.

Liberman AL, Daruwalla VJ, Collins JD, Maas MB, Botelho MP, Ayache JB, Carr J, Ruff I, Bernstein RA, Alberts MJ, Prabhakaran S.

Stroke. 2014 Aug;45(8):2324-9. doi: 10.1161/STROKEAHA.114.005539. Epub 2014 Jun 17.

PMID:
24938843
39.

Preadmission statin use does not improve functional outcomes or prevent delayed ischemic events in patients with spontaneous subarachnoid hemorrhage.

Lizza BD, Kosteva A, Maas MB, Rosenberg NF, Liotta E, Guth J, Levasseur-Franklin KE, Naidech AM.

Pharmacotherapy. 2014 Aug;34(8):811-7. doi: 10.1002/phar.1436. Epub 2014 May 7.

PMID:
24807391
40.

Subarachnoid extension of primary intracerebral hemorrhage is associated with fevers.

Guth JC, Nemeth AJ, Rosenberg NF, Kosteva AR, Bauer RM, Liotta EM, Prabhakaran S, Naidech AM, Maas MB.

Neurocrit Care. 2014 Apr;20(2):187-92. doi: 10.1007/s12028-013-9888-0.

PMID:
24186539
41.

Predictors of intraventricular extension of intracerebral hemorrhage confounded by antithrombotic medication exposure.

Maas MB, Caprio FZ, Rosenberg NF, Naidech AM.

Crit Care Med. 2013 Nov;41(11):e394. doi: 10.1097/CCM.0b013e3182a11e81. No abstract available.

42.

Intracerebral hemorrhage and delirium symptoms. Length of stay, function, and quality of life in a 114-patient cohort.

Naidech AM, Beaumont JL, Rosenberg NF, Maas MB, Kosteva AR, Ault ML, Cella D, Ely EW.

Am J Respir Crit Care Med. 2013 Dec 1;188(11):1331-7. doi: 10.1164/rccm.201307-1256OC.

43.

Predictors of 30-day readmission after subarachnoid hemorrhage.

Singh M, Guth JC, Liotta E, Kosteva AR, Bauer RM, Prabhakaran S, Rosenberg N, Bendok BR, Maas MB, Naidech AM.

Neurocrit Care. 2013 Dec;19(3):306-10. doi: 10.1007/s12028-013-9908-0.

PMID:
24037248
44.

Predictors of 30-day readmission after intracerebral hemorrhage: a single-center approach for identifying potentially modifiable associations with readmission.

Liotta EM, Singh M, Kosteva AR, Beaumont JL, Guth JC, Bauer RM, Prabhakaran S, Rosenberg NF, Maas MB, Naidech AM.

Crit Care Med. 2013 Dec;41(12):2762-9. doi: 10.1097/CCM.0b013e318298a10f.

45.

Infarct volume predicts delayed recovery in patients with subarachnoid hemorrhage and severe neurological deficits.

Rosenberg NF, Liebling SM, Kosteva AR, Maas MB, Prabhakaran S, Naidech AM.

Neurocrit Care. 2013 Dec;19(3):293-8. doi: 10.1007/s12028-013-9869-3.

PMID:
23860664
46.

Surveillance neuroimaging and neurologic examinations affect care for intracerebral hemorrhage.

Maas MB, Rosenberg NF, Kosteva AR, Bauer RM, Guth JC, Liotta EM, Prabhakaran S, Naidech AM.

Neurology. 2013 Jul 9;81(2):107-12. doi: 10.1212/WNL.0b013e31829a33e4. Epub 2013 Jun 5.

47.

Delayed intraventricular hemorrhage is common and worsens outcomes in intracerebral hemorrhage.

Maas MB, Nemeth AJ, Rosenberg NF, Kosteva AR, Prabhakaran S, Naidech AM.

Neurology. 2013 Apr 2;80(14):1295-9. doi: 10.1212/WNL.0b013e31828ab2a7. Epub 2013 Mar 20.

48.

Risk adjustment for case mix and the effect of surgeon volume on morbidity.

Maas MB, Jaff MR, Rordorf GA.

JAMA Surg. 2013 Jun;148(6):532-6. doi: 10.1001/jamasurg.2013.1509.

PMID:
23426886
49.

Subarachnoid extension of primary intracerebral hemorrhage is associated with poor outcomes.

Maas MB, Nemeth AJ, Rosenberg NF, Kosteva AR, Guth JC, Liotta EM, Prabhakaran S, Naidech AM.

Stroke. 2013 Mar;44(3):653-7. doi: 10.1161/STROKEAHA.112.674341. Epub 2013 Feb 7.

PMID:
23391854
50.

Leukoaraiosis on magnetic resonance imaging correlates with worse outcomes after spontaneous intracerebral hemorrhage.

Caprio FZ, Maas MB, Rosenberg NF, Kosteva AR, Bernstein RA, Alberts MJ, Prabhakaran S, Naidech AM.

Stroke. 2013 Mar;44(3):642-6. doi: 10.1161/STROKEAHA.112.676890. Epub 2013 Feb 7.

PMID:
23391853

Supplemental Content

Support Center